A randomized, double-blind clinical trial of a herbal formulation (GlycaCare-II) for the management of type 2 diabetes in comparison with metformin
Abstract Background Type 2 diabetes mellitus (T2DM) is a major public health concern with growing prevalence with multiple debilitating complications. GlycaCare-II is a proprietary herbal formulation supplement for T2DM containing extracts of Cinnamomum cassia, Momordica charantia, Pterocarpus marsu...
Guardado en:
Autores principales: | Muhammed Majeed, Anju Majeed, Kalyanam Nagabhusahnam, Lakshmi Mundkur, Shaji Paulose |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b210bd29830c478fa5deb5e7d7ec8568 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Newly-Diagnosed Diabetes and Sustained Hyperglycemia are Associated with Poorer Outcomes in COVID-19 Inpatients Without Pre-Existing Diabetes
por: Lin L, et al.
Publicado: (2021) -
The Gut Microbial Diversity of Newly Diagnosed Diabetics but Not of Prediabetics Is Significantly Different from That of Healthy Nondiabetics
por: Akshay H. Gaike, et al.
Publicado: (2020) -
Arterial Parameters in Type-2 Diabetes and Healthy Subjects by using Impedance Plethysmography: A Case-control Study
por: Yogesh Kishorbhai Kacha, et al.
Publicado: (2021) -
Glucoherb versus metformin on glycemic markers and glycosylated hemoglobin in prediabetes patients; a clinical trial study
por: Iman Izadi, et al.
Publicado: (2021) -
Sociodemographic and anthropometric risk factors for type 2 diabetes (T2D) in Nador population
por: Kenfaoui Ikram, et al.
Publicado: (2021)